Latest
Autopsy report unveils the cause of Davido’s friend, Tagbo’s death
By Boluwatife Ezekiel Olaleye
The Medical Examiner’s Office autopsy has revealed that alcohol was a substantial factor in the death of a 35-year-old Tagbo Umeike, the friend of Davido who died on his birthday.
The result also showed that he had alcohol and drugs in his system capable of easing a person into the early stages of hypothermia and eventual death.
The toxicology tests detected alcohol (Bacardi 151, 75.5% Alcohol) and topiramate, a medication for epilepsy and/or migraines in a man’s system.
Tagbo’s blood-alcohol concentration (BAC) was at 0.112, higher than the 0.08 legal limit for normal human being state, the coroner’s office stated.
ALSO SEE: Tagbo’s Death: Why Police isn’t interrogating Davido
While his family claims that Tagbo “didn’t have a prescription for any type of topiramate medication”, the coroner’s office stated that the amount of drug in Tagbos’ system was in the “therapeutic range.”
A statement by the coroner’s office said, “Alcohol and topiramate are synergistic. When combined, the effect of either or both drugs is enhanced.”
“Topiramate, like alcohol, can cause dizziness, impaired memory, impaired concentration, poor coordination, confusion and impaired judgment.
“Central nervous system depression, or impairment, combined with cold exposure can hasten the onset of hypothermia and death.”
-
Education1 week agoUniversity of Ibadan releases 2026/2027 post-UTME screening results
-
Football1 week agoUnpaid £185m Club World Cup fund sparks fresh FIFA controversy
-
Football3 days agoFrance confirms U-20 Women’s World Cup participation amid FIFA-UEFA rift
-
Business3 days agoNigeria’s external debt service falls 31.5% to $954m in Q1 2026
-
Business1 week agoBreaking: NNPCL reduces pump price of petrol as competition intensifies
-
Featured2 days agoOsun Governorship Election: Adeleke faces tough test as APC, ADC mount challenge
-
Latest2 days agoNFF denies calling for Infantino’s resignation
-
Business2 days agoNaira at ₦1,360/$: Can the currency’s new stability last?


